Affidea Group

Affidea Group, established in 1991, is a prominent medical service provider specializing in diagnostic imaging, cancer detection, and advanced cancer treatment services. Operating within the medical testing and clinical laboratories sector, the company leverages state-of-the-art technology to deliver high-quality healthcare solutions. By maintaining a focus on precision and patient-centric care, Affidea Group has solidified its position as a leader in the European healthcare market, providing essential diagnostic services that support complex medical decision-making processes across various clinical environments.

The organization maintains a robust operational footprint with 1,000-5,000 employees across 2 locations. Affidea Group integrates sophisticated diagnostic imaging and outpatient care services to address the growing demand for specialized oncology and radiology support. Their service portfolio includes comprehensive cancer care, diagnostic imaging, and specialized treatment services designed to improve patient outcomes through early detection and evidence-based clinical protocols. The company’s commitment to technological excellence ensures that all diagnostic procedures meet rigorous international standards for accuracy and safety.

With a strategic headquarters based in The Hague, Netherlands, Affidea Group continues to expand its influence in the B2B and B2C healthcare sectors. The company’s operational model emphasizes the deployment of advanced medical equipment and the recruitment of highly skilled medical professionals to maintain service quality. Meet Affidea Group's team to learn about their leadership and the experts driving their clinical innovation. By prioritizing patient safety and diagnostic precision, the firm remains a critical partner for healthcare systems seeking reliable, high-volume diagnostic and treatment capabilities throughout Europe.